Media stories about Mesoblast Limited (NASDAQ:MESO) have trended somewhat positive on Tuesday, Accern Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Mesoblast Limited earned a coverage optimism score of 0.19 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.8576170387686 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
These are some of the news headlines that may have effected Accern Sentiment’s scoring:
- Mesoblast Limited – American De (NASDAQ:MESO) Traded -9.1% Below Its 50 Day Moving Average – Modern Readers (modernreaders.com)
- Mesoblast Limited (MESO) Given Consensus Recommendation of “Hold” by Brokerages (americanbankingnews.com)
- Mesoblast Limited (MESO) stock changed 113923 shares unusually on Friday – Voice Of Analysts (analystsbuzz.com)
- ETFs with exposure to Mesoblast Ltd. : September 6, 2017 (finance.yahoo.com)
A number of equities research analysts have recently weighed in on MESO shares. Zacks Investment Research downgraded Mesoblast Limited from a “buy” rating to a “sell” rating in a research note on Wednesday, May 17th. Maxim Group set a $14.00 price target on Mesoblast Limited and gave the stock a “buy” rating in a research note on Thursday, May 25th. Cantor Fitzgerald started coverage on Mesoblast Limited in a research note on Wednesday, June 7th. They set a “buy” rating and a $20.00 price target for the company. BidaskClub downgraded Mesoblast Limited from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Finally, Credit Suisse Group set a $11.00 price target on Mesoblast Limited and gave the stock a “hold” rating in a research note on Tuesday, July 18th. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the company’s stock. Mesoblast Limited currently has a consensus rating of “Hold” and an average price target of $13.64.
Shares of Mesoblast Limited (NASDAQ:MESO) traded down 3.24% on Tuesday, hitting $5.67. The company had a trading volume of 17,947 shares. Mesoblast Limited has a 12-month low of $4.01 and a 12-month high of $12.50. The firm’s market capitalization is $481.29 million. The firm has a 50 day moving average of $6.76 and a 200-day moving average of $8.29.
Mesoblast Limited Company Profile
Receive News & Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related companies with MarketBeat.com's FREE daily email newsletter.